
BLU
Healthcare · Biotechnology · $1.87B market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2023
EPS trend, 90 days to now · -20.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 12, 2023 | After the close | -0.18 | -0.20 | -11.1% |
| Mar 21, 2023 | After the close | -0.19 | -0.15 | +21.1% |
| Nov 14, 2022 | After the close | -0.17 | -0.20 | -17.6% |
| Aug 10, 2022 | After the close | -0.16 | -0.18 | -12.5% |
| May 11, 2022 | After the close | -0.18 | -0.13 | +27.8% |
| Feb 23, 2022 | After the close | -0.26 | -0.18 | +30.8% |
| Nov 10, 2021 | After the close | -0.22 | -0.29 | -31.8% |
| Aug 11, 2021 | After the close | -0.21 | -0.23 | -9.5% |
| May 10, 2021 | After the close | -0.14 | -0.20 | -42.9% |
| Feb 25, 2021 | After the close | -0.13 | -0.10 | +23.1% |
| Nov 12, 2020 | Before the open | -0.18 | -0.12 | +33.3% |
| Aug 13, 2020 | Before the open | -0.22 | -0.19 | +13.6% |
| May 14, 2020 | After the close | -0.27 |
BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval,…
| -0.24 |
| +11.1% |
| Feb 27, 2020 | After the close | -0.18 | -0.26 | -44.4% |
| Nov 14, 2019 | Before the open | -0.18 | -0.18 | 0.0% |
| Aug 8, 2019 | Before the open | -0.07 | -0.14 | -100.0% |
| May 8, 2019 | After the close | -0.01 | -0.08 | -700.0% |
| Feb 21, 2019 | Before the open | -0.01 | -0.05 | -400.0% |
| Nov 14, 2018 | After the close | -0.02 | -0.11 | -450.0% |
| Aug 8, 2018 | Before the open | -0.02 | -0.04 | -100.0% |
| May 15, 2018 | After the close | -0.01 | -0.07 | -600.0% |
| Feb 21, 2018 | Before the open | -0.06 | -0.11 | -89.7% |